Localization of the hypothetical protein Cpn0797 in the cytoplasm of Chlamydia pneumoniae-infected host cells

Infection and Immunity

Volumn 74, Issue 11, 2006, Pages 6479-6486

  Dong, Feng ^a   Flores, Rhonda ^a   Chen, Ding ^a   Luo, Jianhua ^a   Zhong, Youmin ^a   Wu, Zhongming ^a   Zhong, Guangming ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PROTEIN CPAFCP; PROTEIN CPN0796; PROTEIN CPN0797; UNCLASSIFIED DRUG;

ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CYTOPLASM; HELA CELL; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN SECRETION;

ANTIGENS, BACTERIAL; CHLAMYDOPHILA PNEUMONIAE; CYTOPLASM; CYTOSOL; HELA CELLS; HUMANS; OPEN READING FRAMES;

EID: 33750447989     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00855-06     Document Type: Article

References (26)

1. Campbell, L. A., and C. C. Kuo. 2002. Chlamydia pneumoniae pathogenesis. J. Med. Microbiol. 51:623-625.
2. Campbell, L. A., and C. C. Kuo. 2004. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis? Nat. Rev. Microbiol. 2:23-32.
3. Campbell, L. A., T. Nosaka, M. E. Rosenfeld, K. Yaraei, and C. C. Kuo. 2005. Tumor necrosis factor alpha plays a role in the acceleration of atherosclerosis by Chlamydia pneumoniae in mice. Infect. Immun. 73:3164-3165.
4. Carabeo, R. A., D. J. Mead, and T. Hackstadt. 2003. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc. Natl. Acad. Sci. USA 100:6771-6776.
5. Fan, P., F. Dong, Y. Huang, and G. Zhong. 2002. Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors is required for major histocompatibility complex antigen expression. Infect. Immun. 70:345-349.
6. Fan, T., H. Lu, H. Hu, L. Shi, G. A. McClarty, D. M. Nance, A. H. Greenberg, and G. Zhong. 1998. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 187:487-496.
7. Grayston, J. T. 1992. Chlamydia pneumoniae, strain TWAR pneumonia. Annu. Rev. Med. 43:317-323.
8. Greene, W., Y. Xiao, Y. Huang, G. McClarty, and G. Zhong. 2004. Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis. Infect. Immun. 72:451-460.
9. Hackstadt, T. 1998. The diverse habitats of obligate intracellular parasites. Curr. Opin. Microbiol. 1:82-87.
10. Hackstadt, T., E. R. Fischer, M. A. Scidmore, D. D. Rockey, and R. A. Heinzen. 1997. Origins and functions of the chlamydial inclusion. Trends Microbiol. 5:288-293.
11. Hackstadt, T., D. D. Rockey, R. A. Heinzen, and M. A. Scidmore. 1996. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J. 15:964-977.
12. Hackstadt, T., M. A. Scidmore, and D. D. Rockey. 1995. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc. Natl. Acad. Sci. USA 92:4877-4881.
13. Heuer, D., V. Brinkmann, T. F. Meyer, and A. J. Szczepek. 2003. Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell Microbiol. 5:315-322.
14. Hu, H., G. N. Pierce, and G. Zhong. 1999. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Investig. 103:747-753.
15. Kuo, C. C., L. A. Campbell, and M. E. Rosenfeld. 2002. Chlamydia pneumoniae infection and atherosclerosis: methodological considerations. Circulation 105: e34.
16. Kuo, C. C., J. T. Grayston, L. A. Campbell, Y. A. Goo, R. W. Wissler, and E. P. Benditt. 1995. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc. Natl. Acad. Sci. USA 92:6911-6914.
17. Kuo, C. C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
18. -/- mouse model within six months. Mol. Cell Biochem. 215:123-128.
19. Scidmore, M. A., E. R. Fischer, and T. Hackstadt. 1996. Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J. Cell Biol. 134:363-374.
20. Sharma, J., Y. Niu, J. Ge, G. N. Pierce, and G. Zhong. 2004. Heat-inactivated C. pneumoniae organisms are not atherogenic. Mol. Cell Biochem. 260:147-152.
21. Sharma, J., Y. Zhong, F. Dong, J. M. Piper, G. Wang, and G. Zhong. 2006. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect. Immun. 74:1490-1499.
22. Shaw, A. C., B. B. Vandahl, M. R. Larsen, P. Roepstorff, K. Gevaert, J. Vandekerckhove, G. Christiansen, and S. Birkelund. 2002. Characterization of a secreted Chlamydia protease. Cell Microbiol. 4:411-424.
23. Su, H., G. McClarty, F. Dong, G. M. Hatch, Z. K. Pan, and G. Zhong. 2004. Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J. Biol. Chem. 279:9409-9416.
24. Vandahl, B. B., A. Stensballe, P. Roepstorff, G. Christiansen, and S. Birkelund. 2005. Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism. Cell Microbiol. 7:825-836.
25. Xiao, Y., Y. Zhong, W. Greene, F. Dong, and G. Zhong. 2004. Chlamydia trachomatis infection inhibits both Bax and Bak activation induced by staurosporine. Infect. Immun. 72:5470-5474.
26. Zhong, G., P. Fan, H. Ji, F. Dong, and Y. Huang. 2001. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193:935-942.